BESIVANCE
Total Payments
$1.0M
Transactions
9,682
Doctors
4,587
Companies
6
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $78.00 | 4 | 4 |
| 2023 | $430.32 | 4 | 3 |
| 2022 | $259.07 | 15 | 14 |
| 2021 | $2,381 | 156 | 79 |
| 2020 | $13,980 | 393 | 243 |
| 2019 | $102,235 | 2,112 | 1,360 |
| 2018 | $132,488 | 2,429 | 1,705 |
| 2017 | $759,636 | 4,569 | 2,850 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Charitable Contribution | $614,693 | 12 | 60.8% |
| Food and Beverage | $196,216 | 9,435 | 19.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $134,230 | 43 | 13.3% |
| Unspecified | $23,100 | 7 | 2.3% |
| Consulting Fee | $21,224 | 16 | 2.1% |
| Travel and Lodging | $19,360 | 77 | 1.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,150 | 10 | 0.2% |
| Education | $365.52 | 79 | 0.0% |
| Gift | $147.90 | 3 | 0.0% |
Payments by Type
General
$988,387
9,675 transactions
Research
$23,100
7 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| EMPIRIC USE OF BESIFLOXACIN FOR THE TREATMENT OF OCULAR STAPHYLOCOCCAL INFECTIONS | Bausch Health US, LLC | $16,600 | 0 |
| EMPIRIC USE OF BESIFLOXACIN FOR THE TREATMENT OF OCULAR STAPHYLOCOCCAL INFECTIONS | Valeant Pharmaceuticals North America LLC | $6,500 | 0 |
Top Doctors Receiving Payments for BESIVANCE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Ophthalmology | Birmingham, MI | $169,922 | 1 |
| , M.D | Plastic and Reconstructive Surgery | Huntsville, AL | $110,396 | 1 |
| , M.D | Ophthalmology | Mesa, AZ | $77,909 | 1 |
| , M.D | Ophthalmology | Detroit, MI | $63,311 | 1 |
| , M.D | Ophthalmology | Owings Mills, MD | $52,603 | 3 |
| , M.D | Ophthalmology | Saint Joseph, MI | $33,724 | 1 |
| , MD | Ophthalmology | Salt Lake City, UT | $27,654 | 1 |
| , M.D | Ophthalmology | Mililani, HI | $27,654 | 1 |
| Mark Basta | — | Hayward, CA | $23,150 | 9 |
| , MD | Ophthalmology | Colton, CA | $22,888 | 28 |
| , OD | Optometrist | Tahlequah, OK | $22,228 | 1 |
| , MD | Ophthalmology | Kennewick, WA | $22,174 | 1 |
| , M.D | Ophthalmology | Houston, TX | $16,146 | 22 |
| , MD | Ophthalmology | Lexington, KY | $15,259 | 25 |
| , MD | Ophthalmology | Germantown, TN | $14,104 | 20 |
| , M.D | Ophthalmology | Bradenton, FL | $12,154 | 10 |
| , O.D | Optometrist | Austin, TX | $11,004 | 16 |
| , M.D | Ophthalmology | Los Angeles, CA | $9,014 | 5 |
| , MD | Ophthalmology | Bradenton, FL | $8,457 | 9 |
| , M.D | Ophthalmology | Memphis, TN | $7,682 | 16 |
| , O.D | Optometrist | Concord, NC | $6,395 | 8 |
| , MD | Ophthalmology | Allentown, PA | $6,133 | 7 |
| , M.D | Ophthalmology | Carlsbad, CA | $5,726 | 10 |
| , OD | Optometrist | Lexington, KY | $5,274 | 11 |
| , O.D., M.S | Optometrist | Columbus, OH | $5,073 | 1 |
Ad
Manufacturing Companies
- Valeant Pharmaceuticals North America LLC $759,635
- Bausch & Lomb, a division of Bausch Health US, LLC $225,274
- Bausch Health US, LLC $25,740
- Bausch & Lomb Americas Inc. $767.39
- Ortho Dermatologics, a division of Bausch Health US, LLC $60.40
- PFIZER INC. $10.50
Product Information
- Type Drug
- Total Payments $1.0M
- Total Doctors 4,587
- Transactions 9,682
About BESIVANCE
BESIVANCE is a drug associated with $1.0M in payments to 4,587 healthcare providers, recorded across 9,682 transactions in the CMS Open Payments database. The primary manufacturer is Valeant Pharmaceuticals North America LLC.
Payment data is available from 2017 to 2024. In 2024, $78.00 was paid across 4 transactions to 4 doctors.
The most common payment nature for BESIVANCE is "Charitable Contribution" ($614,693, 60.8% of total).
BESIVANCE is associated with 2 research studies, including "EMPIRIC USE OF BESIFLOXACIN FOR THE TREATMENT OF OCULAR STAPHYLOCOCCAL INFECTIONS" ($16,600).